Infusio

What Infusio does

Infusio, operated by Global Health Resource GmbH, is a Frankfurt-based integrative and regenerative medicine practice founded in 2010 by British Naturopath Philip Battiade and led by CEO Daniel Beyer. The company treats chronic degenerative diseases, cancer, Lyme disease, and sports-related injuries through a proprietary "Five Steps to Health" framework — Immune Modulation, Cellular Optimization, Detoxification, Disease-Specific Treatment, and Mind-Body Medicine — delivered in a spa-like treatment environment. Core technical modalities include Stromal Vascular Fraction (SVF) adipose-derived stem cell therapy, exosome therapy derived from young healthy mesenchymal stem cells, personalized dendritic cell therapy for cancer, regional hyperthermia, IV therapy, ozone therapy, peptide vaccines, photobiomodulation, thymus therapy, and colon hydrotherapy, supported by prevention diagnostics (Bio Scan, thermography, imaging) and rejuvenation services.

The company operates treatment centers in Frankfurt (Germany), Shanghai (China), and Beverly Hills (USA, via the Performance sub-brand for elite athletes), with stated presence in five countries. Revenue is generated through fee-for-service medical treatments (most not covered by insurance), the Infusio Elite Private Membership Association which provides US treatment access through a membership legal structure, and the Infusio Life supplements product line. Go-to-market is direct-to-consumer and consultation-driven: prospective patients complete an intake form specifying program interest and geography, after which a Patient Care Coordinator follows up, supported by free consultations, content marketing, social media, and word-of-mouth referrals. International patients are served with full logistical concierge including travel, accommodation, and transportation arrangements.

Name

Infusio

Legal name

Global Health Resource GmbH

Website

https://infusio.org

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Infusio is a Frankfurt-based integrative and regenerative medicine practice treating chronic degenerative diseases, cancer, Lyme disease, and sports injuries via stem cell, exosome, and hyperthermia therapies, serving international patients across centers in Germany, China, and the United States.

Ownership category

akta.pro rank

Product category

Integrative and Regenerative Medicine

NAICS

All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)

akta.pro secondary industries

Cell Therapy Developers (Autologous) (HLAAABAA), Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics) (HLAAAGAL)

Keywords

• Integrative medicine
• Regenerative medicine
• Stem cell therapy
• Chronic disease treatment
• Naturopathic medicine

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Medical Treatment Services: Fees for integrative medical treatments including Lyme disease programs, cancer care, stem cell therapy, and surgical optimization. Treatment is provided at spa-like treatment centers with individualized approach. Most treatments not covered by insurance.
2. Infusio Elite Private Membership: Private membership association model providing exclusive access to treatments and services in the US. Membership-based access to treatments and information.
3. Supplements: Sale of nutritional supplements and health products including Infusio Life all-natural product line.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Infusio operates integrative regenerative medicine treatment centers delivering the proprietary Five Steps to Health framework, combining traditional European naturopathic medicine with cutting-edge biological therapies. Core services include Lyme disease programs, cancer care, cell therapy (SVF stem cells, exosomes, dendritic cell therapy), and surgical optimization, delivered through treatment centers in Frankfurt, Shanghai, and Beverly Hills.

Product overview

Infusio is a regenerative and integrative medicine practice offering a multi-level approach to treating chronic degenerative diseases and cancer. The core offering is the Five Steps to Health framework, which integrates traditional European medicine with cutting-edge science through medical, biological, and bio-energetic modalities. The company operates several treatment programs including Lyme Disease, Cancer Care, Cell Therapy, and Surgical Optimization programs. Treatment modalities include Stromal Vascular Fraction (SVF) stem cell therapy, Dendritic Cell Therapy, Exosome Therapy, IV Therapy, Ozone Therapy, Peptide Vaccines, Photobiomodulation, Regional Hyperthermia, Thymus Therapy, and Colon Hydrotherapy. Additional service categories encompass Prevention Services (diagnostics and screening) and Rejuvenation Services (spa and wellness treatments). The company also operates Performance, a sports medicine sub-brand, and Infusio Elite, a private membership association. All treatments are personalized to individual patient needs.

Differentiator

Problem solved

Functional benefit

Brands

• Performance: Sub-brand focused on orthopedic rejuvenation, fitness optimization, and athletic performance using stem cell technology

Products and services

• Lyme Disease Program An integrative treatment program that addresses multiple aspects of Lyme disease at a foundational level using the Five Steps to Health approach: immune modulation, cellular optimization, detoxification, disease-specific treatment, and mind-body medicine. Designed for patients with chronic Lyme disease unresponsive to conventional care.
• Cancer Care Program An integrative approach to cancer therapy using cutting-edge science and technology, including regional hyperthermia, dendritic cell therapy, and immune modulation. Designed for patients seeking non-toxic or complementary cancer treatments.
• Cell Therapy Program A stem cell therapy program using cutting-edge treatments such as Stromal Vascular Fraction (SVF) to restore, strengthen, and optimize the body. Used for joint conditions, neurological disorders, autoimmune conditions, and age-related decline.
• Surgical Optimization Program Pre- and post-surgical optimization services designed to support surgical outcomes and accelerate recovery through immune modulation and cellular optimization.
• Stromal Vascular Fraction (SVF) Therapy A stem cell therapy derived from the patient's own adipose tissue, containing mesenchymal stem cells, growth factors, endothelial precursor cells, T-regulatory cells, macrophages, smooth muscle cells, pericytes, and preadipocytes. Triggers a systemic healing response for conditions including rheumatoid arthritis, osteoarthritis, Crohn's disease, neuropathy, ALS, Parkinson's, migraine, and diabetes.
• Dendritic Cell Therapy A personalized cancer immunotherapy that harnesses vaccine principles to generate and boost a personalized immune system attack against the patient's own cancer cells.
• Exosome Therapy Regenerative treatment using purified exosomes from young, healthy Mesenchymal Stem Cells that serve as messengers for cell-to-cell communication, enabling cell optimization, repair processes, and mobilization of the body's healing mechanisms.
• IV Therapy Intravenous infusion of vitamins (e.g., vitamin C) and minerals (e.g., magnesium) to promote cellular homeostasis and wellbeing.
• Ozone Therapy A complementary medicine treatment modality that uses medical-grade ozone to support the body's healing and detoxification processes.
• Regional Hyperthermia A cancer treatment technology that uses targeted heat to treat tumors, integrated within the Cancer Care Program as part of Infusio's integrative oncology approach.
• Colon Hydrotherapy

Quantifiable outcome

• SVF stem cell therapy has been shown to benefit patients with rheumatoid arthritis, joint replacement, osteoarthritis, Crohn's disease, neurological conditions (neuropathy, ALS, Parkinson's), migraine, tension headaches, and diabetes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Stemcell Technologies: A large, established life sciences tools and services provider in the cell therapy and regenerative medicine space. Comparable to Infusio as a broad incumbent operating across the cell therapy ecosystem that Infusio's SVF and exosome programs sit within.
• Liv Hospital: International hospital group operating in Turkey and beyond, offering stem cell therapies and integrative oncology to medical tourists. Comparable to Infusio as a broader international healthcare provider in the regenerative medicine space.

Emerging players

• Cellect Biotechnology: Cell therapy developer focused on autologous cell selection technologies. Comparable to Infusio in the autologous cell therapy domain, though operating as a technology developer rather than a treatment provider.
• BioViva: A company working on gene and cell therapies aimed at age-related decline, offering services in the regenerative and longevity medicine space. Comparable to Infusio's regenerative medicine and rejuvenation service lines.

Direct peers

• Celltex Therapeutics: US-based stem cell therapy provider offering autologous mesenchymal stem cell banking and treatments. Direct peer in autologous adult stem cell therapy delivery, comparable to Infusio's SVF-based Cell Therapy Program.
• Okyanos Center for Regenerative Medicine: An adult stem cell therapy clinic treating chronic degenerative conditions using adipose-derived SVF. Closely comparable to Infusio's Stromal Vascular Fraction-based treatment approach.
• Hallwang Clinic: A European private oncology and integrative medicine clinic offering dendritic cell therapy, hyperthermia, and other immunotherapies to international patients. Highly comparable to Infusio's cancer care and cell therapy programs, with a similar international medical-tourist model.
• Verita Neuro: International regenerative medicine provider offering stem cell therapies for neurological and chronic conditions to medical tourists. Comparable to Infusio's neurology and chronic disease treatment segments.
• Stemaid Institute: A regenerative medicine clinic offering stem cell and exosome-based therapies for chronic and degenerative conditions. Direct peer to Infusio's Cell Therapy Program and exosome offerings.
• Immunocine Cancer Center: Integrative oncology clinic offering dendritic cell therapy and immunotherapies to cancer patients internationally. Direct peer to Infusio's Cancer Care Program using patient-derived immune cell therapies.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/infusioffm
• YouTubeyoutube.com/user/GHResource
• Facebookfacebook.com/Infusiofrankfurt
• Instagraminstagram.com/infusiofrankfurt
• LinkedInlinkedin.com/company/infusio

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Infusio